Rosehip and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rosehip (rose hip) and Furosemide (furosemide). Common drug interactions include dysphagia among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Rosehip and Furosemide. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Rosehip?

Rosehip has active ingredients of rose hip. eHealthMe is studying from 140 Rosehip users. Check the latest studies of Rosehip.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.



On Jul, 14, 2026

12 people who take Rosehip and Furosemide together, and have interactions are studied.

Rosehip and Furosemide drug interactions.

What are the common drug interactions of Rosehip and Furosemide, by gender? *:

female:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Abdominal pain upper
  3. Cardiac disorder
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Decreased appetite
  6. Diarrhoea
  7. Dysgeusia (disorder of the sense of taste)
  8. Feeding disorder (when children refuse to eat certain food groups)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypotension (abnormally low blood pressure)

male:

  1. Haemoglobin decreased
  2. Blood creatinine decreased
  3. Heart rate increased
  4. Hepatoblastoma (liver cancer)
  5. Hepatocellular carcinoma (liver cancer)
  6. Hypopnoea (decrease in the breathing rate)
  7. Hypoxia (low oxygen in tissues)
  8. Increased bronchial secretion
  9. Joint injury
  10. Lower respiratory tract infection

What are the common drug interactions of Rosehip and Furosemide, by age (0-1 to 60+)? *:

0-1:

  1. Blood creatinine decreased
  2. Blood potassium increased
  3. Cellulitis (infection under the skin)
  4. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  5. Dyspnoea (difficult or laboured respiration)
  6. Haematocrit decreased
  7. Haemoglobin decreased
  8. Heart rate increased
  9. Hepatoblastoma (liver cancer)
  10. Hepatocellular carcinoma (liver cancer)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Ankle fracture
  3. Aphonia (inability to produce voice)
  4. Fall
  5. Foot fracture
  6. Impaired healing
  7. Pain in extremity
  8. Peripheral swelling
  9. Pulmonary thrombosis (scarring in the lungs)
  10. Speech disorder

50-59:

n/a

60+:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Abdominal pain upper
  3. Joint swelling
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Micturition urgency (urgency to pass the urine)
  6. Pain
  7. Weight decreased
  8. White blood cell count decreased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Death

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 16.67%
  2. Breast Cancer Female: 2 people, 16.67%
  3. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 8.33%
  4. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 8.33%
  5. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 8.33%
  6. Insomnia (sleeplessness): 1 person, 8.33%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
  8. High Blood Pressure: 1 person, 8.33%
  9. Hidradenitis (chronic disease of a type of sweat gland): 1 person, 8.33%
  10. Drowsiness: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Rosehip and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rosehip and Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rosehip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rosehip and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on rose hip and furosemide (the active ingredients of Rosehip and Furosemide, respectively), and Rosehip and Furosemide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: